Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) EPS (Weighted Average and Diluted) (2019 - 2025)

Orthopediatrics (KIDS) has disclosed EPS (Weighted Average and Diluted) for 7 consecutive years, with -$0.43 as the latest value for Q4 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 38.57% to -$0.43 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.69, a 3.05% decrease, with the full-year FY2025 number at -$1.69, down 3.05% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.43 for Q4 2025 at Orthopediatrics, up from -$0.5 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.91 in Q3 2022 to a low of -$0.7 in Q4 2024.
  • A 5-year average of -$0.25 and a median of -$0.3 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 927.27% in 2022; the steepest drop was 3800.0% in 2022.
  • Orthopediatrics' EPS (Weighted Average and Diluted) stood at $0.01 in 2021, then tumbled by 3800.0% to -$0.37 in 2022, then rose by 21.62% to -$0.29 in 2023, then plummeted by 141.38% to -$0.7 in 2024, then skyrocketed by 38.57% to -$0.43 in 2025.
  • Per Business Quant, the three most recent readings for KIDS's EPS (Weighted Average and Diluted) are -$0.43 (Q4 2025), -$0.5 (Q3 2025), and -$0.3 (Q2 2025).